Atopic Dermatitis Treatment Market Size Estimated to Reach $21.5 Billion by 2025

Atopic Dermatitis Treatment Market Overview Atopic Dermatitis Treatment Market size is estimated to reach $21.5 Bn by 2025 and is poised to grow at a CAGR of 13.13% during the forecast period 2020-2025. Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen and cracked skin. The affected area cause white fluid and require treatment. The atopic dermis usually begins in childhood and usually worsen with age. Atopic dermatitis is caused by a genetic disorder, environmental exposure, immune system dysfunction, and difficulty in permeability of the Skin. The market for the treatment of atopic dermatitis is driven by factors such as the launch of new products and the large patient population. The North American market is estimated to register a healthy CAGR over the forecast period 2020-2025. The increasing incidence of atopic dermatitis, rising treatment levels, and rising drug prices are among the most important factors in the market. Key Takeaways Geographically, North America had the largest market for Atopic Dermatitis Treatment in 2019, owing to the growing population and rising treatment levels. The atopic dermatitis treatment market is driven by factors such as the launch of new products and a pool of a large population of patients. Strict government regulations on product approval are set to dampen market growth. Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Atopic Dermatitis Treatment Market report. By Drug Class - Segment Analysis The global Atopic Dermatitis Treatment market based on the Drug class has Corticosteroids, Calcineurin Inhibitors, PDE4 inhibitors, Biologics and others. Corticosteroids have been the cornerstones of the treatment of atopic dermatitis. As this is a first-line therapy, this class of drugs is projected to maintain a significant share over the forecast period (2020-2025). Corticosteroids accounted for the largest share of the market in 2019. New classes of drugs, such as PDE4 inhibitors and biologics, are projected to gain immense popularity during the forecast period (2020-2025) owing to the increasing acceptance of targeted therapy as well as the introduction of pipeline candidates. By Mode of administration – Segment Analysis Based on Mode of administration, the market is classified into Topical, Oral, and Injectable. Topical products led the market in 2019. Topical corticosteroids are the most widely prescribed drugs for atopic dermatitis. They are often given in combination with moisturizers or emollients for a more effective result. Supporting public and private organizations in managing all operations in hospitals and clinics just to provide effective treatment procedures to increase market share. By Geography - Segment Analysis North America was the largest market for the treatment of atopic dermatitis in 2019, owing to new product launches, early treatment adoption, and lifestyle changes. Europe has the second largest market share. Large-scale investment in R&D in this region is the main driver of the market. The Asia-Pacific region is estimated to grow the fastest during the forecast period 2020-2025, towing to rising health spending and the availability of appropriate treatment. Drivers – Atopic Dermatitis Treatment Market Rise in awareness and Government initiatives Increasing awareness of the availability of treatment for the disease has helped the market stick in recent years. Initiatives taken by governments to ensure better and more affordable treatment and the existence of favorable reimbursement policies are likely to spur the market. Health development and evolution in emerging countries is poised to offer new opportunities during the analysis period. Challenges – Atopic Dermatitis Treatment Market High cost The high cost of therapies is one of the main obstacles to the market rising. However, affordable health measures are being incorporated in all major regions, affecting companies ’pricing strategies as well as reimbursement scenarios. Increased cost awareness, especially in emerging countries, is likely to hamper premium-pricing opportunities for future AD drugs, especially biologics. Atopic Dermatitis Treatment Market Industry outlook: Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Atopic Dermatitis Treatment Market. Key companies of this market include Bayer, LEO Pharma, Mylan, Pfizer, Allergan Plc., Novartis International AG, Bristol-Myers Squibb, Anacor Pharmaceutical Inc., Astellas Pharma Inc. and Sanofi. Acquisitions/Product Launches: In August 2020, Bayer strengthens collaboration with One Drop via nearly $100M in new investment, commitments. In August 2020, Sanofi buys biotech company Principia for $3.4 billion.